BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2858549)

  • 21. Nasal delivery of insulin using bioadhesive chitosan gels.
    Varshosaz J; Sadrai H; Heidari A
    Drug Deliv; 2006; 13(1):31-8. PubMed ID: 16401591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nasal absorption of procyclidine in rats and dogs.
    Jang EJ; Lee YJ; Chung SJ; Shim CK
    Arch Pharm Res; 2001 Jun; 24(3):219-23. PubMed ID: 11440081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bimodal action of [Asu1,7]eel-calcitonin on phosphoinositide hydrolysis in cultured anterior pituitary cells.
    Sortino MA; Canonico PL; Clementi G
    Eur J Pharmacol; 1991 Aug; 207(4):345-50. PubMed ID: 1664337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced absorption of insulin and (Asu(1,7))eel-calcitonin using novel azopolymer-coated pellets for colon-specific drug delivery.
    Tozaki H; Nishioka J; Komoike J; Okada N; Fujita T; Muranishi S; Kim SI; Terashima H; Yamamoto A
    J Pharm Sci; 2001 Jan; 90(1):89-97. PubMed ID: 11064382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aminated gelatin as a nasal absorption enhancer for peptide drugs: evaluation of absorption enhancing effect and nasal mucosa perturbation in rats.
    Wang J; Sakai S; Deguchi Y; Bi D; Tabata Y; Morimoto K
    J Pharm Pharmacol; 2002 Feb; 54(2):181-8. PubMed ID: 11848281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nitric oxide donors can enhance the intestinal transport and absorption of insulin and [Asu(1,7)]-eel calcitonin in rats.
    Fetih G; Habib F; Okada N; Fujita T; Attia M; Yamamoto A
    J Control Release; 2005 Sep; 106(3):287-97. PubMed ID: 15982776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nasal and rectal delivery of insulin with chitosan and N-trimethyl chitosan chloride.
    du Plessis LH; Kotzé AF; Junginger HE
    Drug Deliv; 2010 Aug; 17(6):399-407. PubMed ID: 20429846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reestablishment of the nasal permeability barrier to several peptides following exposure to the absorption enhancer tetradecyl-beta-D-maltoside.
    Arnold JJ; Fyrberg MD; Meezan E; Pillion DJ
    J Pharm Sci; 2010 Apr; 99(4):1912-20. PubMed ID: 19894270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nasal absorption of insulin in dogs.
    Harai S; Ikenaga T; Matsuzawa T
    Diabetes; 1978 Mar; 27(3):296-9. PubMed ID: 25215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calcitonin and insulin in isobutylcyanoacrylate nanocapsules: protection against proteases and effect on intestinal absorption in rats.
    Lowe PJ; Temple CS
    J Pharm Pharmacol; 1994 Jul; 46(7):547-52. PubMed ID: 7996380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stability of [Asu1,7]-eel calcitonin and eel calcitonin in vitro and in vivo.
    Yamauchi H; Shiraki M; Otani M; Matsuo M; Orimo H
    Endocrinol Jpn; 1977 Jun; 24(3):281-5. PubMed ID: 913338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absorption of acetylsalicylic acid from the rat nasal cavity.
    Hussain AA; Iseki K; Kagoshima M; Dittert LW
    J Pharm Sci; 1992 Apr; 81(4):348-9. PubMed ID: 1501071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo conversion of peptide drugs into high molecular weight forms.
    Hori R; Saito Y; Yasuhara M; Okumura K
    J Pharmacobiodyn; 1984 Dec; 7(12):910-6. PubMed ID: 6085348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nasal absorption of metoclopramide from different Carbopol 981 based formulations: In vitro, ex vivo and in vivo evaluation.
    Tas C; Ozkan CK; Savaser A; Ozkan Y; Tasdemir U; Altunay H
    Eur J Pharm Biopharm; 2006 Oct; 64(2):246-54. PubMed ID: 16870409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distribution and metabolism of [Asu1,7]-eel calcitonin in isolated perfused rat pancreas.
    Iwakawa S; Komada F; Okumura K; Hori R
    Chem Pharm Bull (Tokyo); 1984 Apr; 32(4):1546-50. PubMed ID: 6380780
    [No Abstract]   [Full Text] [Related]  

  • 36. Studies on the promoting effects of medium chain fatty acid salts on the nasal absorption of insulin in rats.
    Mishima M; Wakita Y; Nakano M
    J Pharmacobiodyn; 1987 Nov; 10(11):624-31. PubMed ID: 3328778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improvement of the pulmonary absorption of (Asu1,7)-eel calcitonin by various protease inhibitors in rats.
    Morita T; Yamamoto A; Takakura Y; Hashida M; Sezaki H
    Pharm Res; 1994 Jun; 11(6):909-13. PubMed ID: 7937534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Glyceryl Monocaprylate-Modified Chitosan on the Intranasal Absorption of Insulin in Rats.
    Gao M; Sun Y; Kou Y; Shen X; Huo Y; Liu C; Sun Z; Zhang X; Mao S
    J Pharm Sci; 2019 Nov; 108(11):3623-3629. PubMed ID: 31356762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of dose, pH, and osmolarity on nasal absorption of secretin in rats. II: Histological aspects of the nasal mucosa in relation to the absorption variation due to the effects of pH and osmolarity.
    Ohwaki T; Ando H; Kakimoto F; Uesugi K; Watanabe S; Miyake Y; Kayano M
    J Pharm Sci; 1987 Sep; 76(9):695-8. PubMed ID: 11002804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stability of PEGylated salmon calcitonin in nasal mucosa.
    Na DH; Youn YS; Park EJ; Lee JM; Cho OR; Lee KR; Lee SD; Yoo SD; DeLuca PP; Lee KC
    J Pharm Sci; 2004 Feb; 93(2):256-61. PubMed ID: 14705183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.